OL
VRTX icon

OneFund LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

OneFund LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Sell
691
-8
-1% -$3.54K 0.19% 91
2026
Q1 		$313K Sell
699
-35
-5% -$16.3K 0.2% 92
2025
Q4 		$333K Buy
734
+39
+6% +$16.8K 0.2% 92
2025
Q3 		$272K Buy
695
+27
+4% +$11.3K 0.18% 104
2025
Q2 		$297K Sell
668
-9
-1% -$4.15K 0.21% 93
2025
Q1 		$328K Sell
677
-8
-1% -$3.73K 0.33% 78
2024
Q4 		$276K Buy
685
+5
+0.7% +$2.32K 0.26% 90
2024
Q3 		$316K Buy
680
+5
+0.7% +$2.4K 0.32% 77
2024
Q2 		$316K Buy
675
+6
+0.9% +$2.6K 0.34% 77
2024
Q1 		$281K Sell
669
-14
-2% -$5.92K 0.34% 82
2023
Q4 		$278K Buy
+683
New +$252K 0.36% 80

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

OneFund LLC's VRTX Position: Q2 2026 in Review

OneFund LLC reduced its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, selling an estimated $3.54K and leaving 691 shares worth $343K. The position accounts for 0.19% of the portfolio, ranked #91.

OneFund LLC first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • OneFund LLC held 691 shares of Vertex Pharmaceuticals worth $343K as of Q2 2026.
  • OneFund LLC sold 8 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
  • Vertex Pharmaceuticals made up 0.19% of OneFund LLC's portfolio in Q2 2026, its #91 holding.
  • OneFund LLC first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.